| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of immunomodulator effects on infections induced by the friend retrovirus complex in genetically defined mice
|
|
|
1990
|
13 |
S1 |
p. 93-
1 p.
|
artikel
|
| 2 |
Activity of cyclobutyl adenine and cyclobutyl guanine in experimental models of infection with herpes simplex type 1 and type 2 virus
|
|
|
1990
|
13 |
S1 |
p. 109-
1 p.
|
artikel
|
| 3 |
Acyclic nucleoside and nucleotide analogues derived from 1-deaza and 3-deazaadenine
|
|
|
1990
|
13 |
S1 |
p. 55-
1 p.
|
artikel
|
| 4 |
AIDS statistics in spectral maps
|
|
|
1990
|
13 |
S1 |
p. 117-
1 p.
|
artikel
|
| 5 |
Alpha interferon in combination with AZT and activated lymphocytes for the prevention and treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS)
|
|
|
1990
|
13 |
S1 |
p. 45-
1 p.
|
artikel
|
| 6 |
Alterations of productive HIV infection levels in pateints under antiviral therapy
|
|
|
1990
|
13 |
S1 |
p. 103-
1 p.
|
artikel
|
| 7 |
An animal model of neoatal herpes simplex virus infection
|
|
|
1990
|
13 |
S1 |
p. 99-
1 p.
|
artikel
|
| 8 |
An automated evaluation of antiviral compounds in vitro against representatives of several RNA virus families
|
|
|
1990
|
13 |
S1 |
p. 65-
1 p.
|
artikel
|
| 9 |
A need for a multi-parameter virological testing in screening potential AIDS drugs in vitro
|
|
|
1990
|
13 |
S1 |
p. 47-
1 p.
|
artikel
|
| 10 |
An evaluation of human recombinant interferon beta (rIFN-β) against selected positive- and negative-stranded RNA viruses using an MTT assay procedure
|
|
|
1990
|
13 |
S1 |
p. 66-
1 p.
|
artikel
|
| 11 |
An in vitro assay for the evaluation of compounds with potential activity against the Hepatitis B virus
|
|
|
1990
|
13 |
S1 |
p. 69-
1 p.
|
artikel
|
| 12 |
A novel route to 3′-azido-3′-deoxythymidine
|
|
|
1990
|
13 |
S1 |
p. 50-
1 p.
|
artikel
|
| 13 |
Antiherpesviral efficacy of brovavir (BV-araU) in immuno-suppressed mice
|
|
|
1990
|
13 |
S1 |
p. 108-
1 p.
|
artikel
|
| 14 |
Antiherpes virus activity of 5-methoxymethyl-2′-deoxycytidine in combination with deaminase inhibitors
|
|
|
1990
|
13 |
S1 |
p. 43-
1 p.
|
artikel
|
| 15 |
Anti-HIV-1 activity of antiviral compounds, as measured by a quantitative focal immunoassay in CD4+ HeLa cells and a plaque assay in MT-4 cells
|
|
|
1990
|
13 |
S1 |
p. 51-
1 p.
|
artikel
|
| 16 |
Anti-HIV drug activity in vitro : Impact of infection methodology and virus infectivity
|
|
|
1990
|
13 |
S1 |
p. 49-
1 p.
|
artikel
|
| 17 |
Antiinfluenza effect of a plant polyphenolic complex
|
|
|
1990
|
13 |
S1 |
p. 123-
1 p.
|
artikel
|
| 18 |
Antiviral activity and metabolism of 7-isomer derivatives of the purine nucleoside analogue HOE 602
|
|
|
1990
|
13 |
S1 |
p. 55-
1 p.
|
artikel
|
| 19 |
Antiviral activity of anti-cytomegalvirus agents assessed by a flow cytometric method and DNA hybridization techniques
|
|
|
1990
|
13 |
S1 |
p. 57-
1 p.
|
artikel
|
| 20 |
Antiviral activity of cyclobutyl guanine against herpes virus infections
|
|
|
1990
|
13 |
S1 |
p. 110-
1 p.
|
artikel
|
| 21 |
Antiviral activity of LY253963 in BALB/c and swiss mice infected with lethal doses of influenza a virus
|
|
|
1990
|
13 |
S1 |
p. 118-
1 p.
|
artikel
|
| 22 |
Antiviral activity of 5′-O-Methylphosphonyladenosine
|
|
|
1990
|
13 |
S1 |
p. 65-
1 p.
|
artikel
|
| 23 |
Antiviral properties of platinum(II) and palladium(II) complexes containing antiviral nucleoside analogs
|
|
|
1990
|
13 |
S1 |
p. 64-
1 p.
|
artikel
|
| 24 |
Antiviral (RNA) evaluation and synthesis of a series of amaryllidacease alkaloids and related substances
|
|
|
1990
|
13 |
S1 |
p. 60-
1 p.
|
artikel
|
| 25 |
Antripicornarvirus activity of R 77975, a new analog of R 61837 with improved spectrum and potency
|
|
|
1990
|
13 |
S1 |
p. 68-
1 p.
|
artikel
|
| 26 |
A rapid assay for cytomegalovirus antiviral sensitivity
|
|
|
1990
|
13 |
S1 |
p. 57-
1 p.
|
artikel
|
| 27 |
A regulatory perspective of preclinical studies to support antiviral drug activity
|
|
|
1990
|
13 |
S1 |
p. 105-
1 p.
|
artikel
|
| 28 |
A sensitive method for the determination of anti-viral agents and drug content in drug-neoglycorpotein conjugates
|
|
|
1990
|
13 |
S1 |
p. 90-
1 p.
|
artikel
|
| 29 |
Biological properties of Ro 31-8959
|
|
|
1990
|
13 |
S1 |
p. 81-
1 p.
|
artikel
|
| 30 |
Bromovinyldeoxyuridine tratment of herpes simplex virus and varicella-zoster virus infections: A review
|
|
|
1990
|
13 |
S1 |
p. 108-
1 p.
|
artikel
|
| 31 |
Cellular pharmacology of 5′,2′-anhydro-3′-azido-3′deoxythymidine. A potent and selective inhibitor of HIV-1 replication
|
|
|
1990
|
13 |
S1 |
p. 79-
1 p.
|
artikel
|
| 32 |
Chain termination mapping: A novel approach utilizing ganciclovir (DHPG) to identify the origin of replication of the human cytomegalovirus (HCMV)
|
|
|
1990
|
13 |
S1 |
p. 72-
1 p.
|
artikel
|
| 33 |
5-Chloropyrimidine 2',3'-Dideoxyriboside: Synthesis and anti-HIV evaluation
|
|
|
1990
|
13 |
S1 |
p. 40-
1 p.
|
artikel
|
| 34 |
COMBO: New principles and new methods for analyzing synergistic and antagonistic drug combinations in antiviral therapy
|
|
|
1990
|
13 |
S1 |
p. 68-
1 p.
|
artikel
|
| 35 |
Comparison of peroral acyclovir (AVC) and topical 15% idoxuridine in dimethyl sulfoxide (IDU/DMSO) for the treatment of herpes labialis
|
|
|
1990
|
13 |
S1 |
p. 107-
1 p.
|
artikel
|
| 36 |
Comparison of ribavirin analogues in hantaan-infected SCID mice
|
|
|
1990
|
13 |
S1 |
p. 120-
1 p.
|
artikel
|
| 37 |
Comparison of the activity of 4-amino and 4-hydroxyamino acyclic tubercidin analogs against cytomegaloviruses and evaluation of cytotoxicity in mammalian cell lines
|
|
|
1990
|
13 |
S1 |
p. 56-
1 p.
|
artikel
|
| 38 |
Continuous intravenous dextran sulfate in patients with ARC and AIDS
|
|
|
1990
|
13 |
S1 |
p. 116-
1 p.
|
artikel
|
| 39 |
Cutaneous reactions to combination zidovudine-probenecid treatment
|
|
|
1990
|
13 |
S1 |
p. 102-
1 p.
|
artikel
|
| 40 |
7-Deazaguanosine, a new immune enhancer active against RNA viral infections in mice
|
|
|
1990
|
13 |
S1 |
p. 45-
1 p.
|
artikel
|
| 41 |
Design of herpesvirus-specific glycosylation inhibitors
|
|
|
1990
|
13 |
S1 |
p. 71-
1 p.
|
artikel
|
| 42 |
Development of an adult mouse model for studies on protection against rotavirus
|
|
|
1990
|
13 |
S1 |
p. 119-
1 p.
|
artikel
|
| 43 |
Differential susceptibilities of two HIV-1 strains to ddAzThd, ddCdy, ddIno, and PFA in MT-2 cells
|
|
|
1990
|
13 |
S1 |
p. 125-
1 p.
|
artikel
|
| 44 |
Dipyridamole inhibits HIV-1 and potentiates the antiviral activity of dideoxynucleoside drugs in cultured cells: biochemical mechanisms of action
|
|
|
1990
|
13 |
S1 |
p. 79-
1 p.
|
artikel
|
| 45 |
Disruption of Esptein-Barr virus episomal DNA maintenance by a specific oligodeoxyribonucleotide
|
|
|
1990
|
13 |
S1 |
p. 76-
1 p.
|
artikel
|
| 46 |
Dose-escalating study of safety and efficacy of dideoxy-didehydrothymidine (d4T) for HIV infection
|
|
|
1990
|
13 |
S1 |
p. 116-
1 p.
|
artikel
|
| 47 |
Effective inhibition of equine herpesvirus-1 in vivo by phosphonylmethoxyalkyl derivatives of adenine
|
|
|
1990
|
13 |
S1 |
p. 112-
1 p.
|
artikel
|
| 48 |
Effect of castanospermine on virus titers and rauscher MuLV infected NIH swiss mice
|
|
|
1990
|
13 |
S1 |
p. 115-
1 p.
|
artikel
|
| 49 |
Effect of HPMPC on the replication of herpes simplex virus type 1 in monkey kidney and human fibroblast cells
|
|
|
1990
|
13 |
S1 |
p. 88-
1 p.
|
artikel
|
| 50 |
Effect of immunotheraphy on UV induced recurrent herpes simplex virus infections
|
|
|
1990
|
13 |
S1 |
p. 95-
1 p.
|
artikel
|
| 51 |
Effect of natural products of various microbial fermentations from Schering-Plough Corporation on the Replication of HIV-1 as measured by CPE-inhibition assays in infected cells
|
|
|
1990
|
13 |
S1 |
p. 80-
1 p.
|
artikel
|
| 52 |
Effect of oxetanocin-g on replication of hepatitis B virus in vitro and in vivo
|
|
|
1990
|
13 |
S1 |
p. 58-
1 p.
|
artikel
|
| 53 |
Effect of treatment of HPMPC on mortality and pathogenesis of experimental herpes simplex virus infections
|
|
|
1990
|
13 |
S1 |
p. 110-
1 p.
|
artikel
|
| 54 |
Effects of anti-herpetic drugs on ultrastructural localization of herpes simplex virus (HSV) glycoprotein D in cultured cells infected with HSV
|
|
|
1990
|
13 |
S1 |
p. 69-
1 p.
|
artikel
|
| 55 |
Effects of 28 day treatment wit azidothymidine (AZT) initiated 1 to 72 hours after infection with simian immunodeficiency virus (SIV)
|
|
|
1990
|
13 |
S1 |
p. 114-
1 p.
|
artikel
|
| 56 |
Effects of 7-thia-8-oxoguanosine Alone of combination with ribavirin on punta toro virus infections in mice
|
|
|
1990
|
13 |
S1 |
p. 120-
1 p.
|
artikel
|
| 57 |
Efficacy of antivirals against different ocular adenoviral serotypes in vitro , and a new organ culture method
|
|
|
1990
|
13 |
S1 |
p. 63-
1 p.
|
artikel
|
| 58 |
Efficacy of intranasal R 77975 for the prevention of experimentally induced rhinovirus infection and illness
|
|
|
1990
|
13 |
S1 |
p. 103-
1 p.
|
artikel
|
| 59 |
Establishment of an ELISA-based primary antiviral screen and plaque reduction based confirmatory assay for evaluation of compounds against the filovirus ebola under maximum biological containment conditions (BL-4)
|
|
|
1990
|
13 |
S1 |
p. 61-
1 p.
|
artikel
|
| 60 |
Establishment of automated assay systems for detection of anti-HSV agents
|
|
|
1990
|
13 |
S1 |
p. 56-
1 p.
|
artikel
|
| 61 |
Evaluation of infrequent dosing regimes with (S)-1-[(3-hydroxy-2-(phosphonylmethyoxy)propyl]cytosine (HPMPC) in simiam varicella infection in monkeys
|
|
|
1990
|
13 |
S1 |
p. 112-
1 p.
|
artikel
|
| 62 |
Experimental transmission of duck depatitis B virus to pekin ducklings: A potent model for in vivo evaluation of anti-HBV drugs
|
|
|
1990
|
13 |
S1 |
p. 124-
1 p.
|
artikel
|
| 63 |
Expression and characterization of the retroviral protease of the simian immunodeficiency virus
|
|
|
1990
|
13 |
S1 |
p. 82-
1 p.
|
artikel
|
| 64 |
Extended survival and pronostic criteria for acemannan (ACE-M) treated HIV-1 patients(pts)
|
|
|
1990
|
13 |
S1 |
p. 117-
1 p.
|
artikel
|
| 65 |
Failure ofj a chronic retrovirus-induced immunodeficiency syndrome to response to interleukin-2 (IL-2) alone or in combination with azidothyleukin-2
|
|
|
1990
|
13 |
S1 |
p. 115-
1 p.
|
artikel
|
| 66 |
Flow cytometry as an aid in antiviral research
|
|
|
1990
|
13 |
S1 |
p. 90-
1 p.
|
artikel
|
| 67 |
Followed-up observation of antiviral effect of combined treatment of small dosage of interferon and thymosin in patients with chronic hepatitis B
|
|
|
1990
|
13 |
S1 |
p. 123-
1 p.
|
artikel
|
| 68 |
Gag and Pol antisense oligodeoxynucleotides as inhibitors of HIV 1
|
|
|
1990
|
13 |
S1 |
p. 81-
1 p.
|
artikel
|
| 69 |
Hebal extracts and their components as a novel class of inhibitors for HIV-reverse transcriptase
|
|
|
1990
|
13 |
S1 |
p. 53-
1 p.
|
artikel
|
| 70 |
3′-Heterocyclic substituted 3′-deoxythymidines: Synthesis and anti-retrovirus activity
|
|
|
1990
|
13 |
S1 |
p. 52-
1 p.
|
artikel
|
| 71 |
Human cytomegalovirus (HCMV) ocular infection- A rabbit model of chorioretinal disease
|
|
|
1990
|
13 |
S1 |
p. 99-
1 p.
|
artikel
|
| 72 |
Immunodulatory activity of anti-HIV nucleoside analogues on in vivo murine models
|
|
|
1990
|
13 |
S1 |
p. 113-
1 p.
|
artikel
|
| 73 |
Incidence of anti-IFN alpha neutralizing antibodies in hepatitis patients treated with different IFN alpha preparations
|
|
|
1990
|
13 |
S1 |
p. 104-
1 p.
|
artikel
|
| 74 |
Index
|
|
|
1990
|
13 |
S1 |
p. 127-
1 p.
|
artikel
|
| 75 |
Influence of S-adenosylhomocysteine hydrolase inhibitors on S-adenosylhomocysteine/S-adenosylmethionine pool levels in marine L929 cells
|
|
|
1990
|
13 |
S1 |
p. 84-
1 p.
|
artikel
|
| 76 |
Infrequent administration of 9-(2-phosphonylmethoxyethyl)adenine) (PMEA) results in increased anti-retrovirus activity in vivo
|
|
|
1990
|
13 |
S1 |
p. 113-
1 p.
|
artikel
|
| 77 |
Inhibition of duck hepatitis B viral replication by conventional inhibitors and supercoiled DNA active compounds
|
|
|
1990
|
13 |
S1 |
p. 59-
1 p.
|
artikel
|
| 78 |
Inhibitors of HIV proteinase
|
|
|
1990
|
13 |
S1 |
p. 74-
1 p.
|
artikel
|
| 79 |
Inhibitory activity of sulfated polysaccharides against respiratory syncytial virus infection in vitro
|
|
|
1990
|
13 |
S1 |
p. 63-
1 p.
|
artikel
|
| 80 |
Inhibitory effects of (S)-1-3-(3-hydroxy-2-phosphonylmethoxypropyl1)Cytosine and 0-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication and DNA synthesis
|
|
|
1990
|
13 |
S1 |
p. 86-
1 p.
|
artikel
|
| 81 |
Initial pharmacokinetic studies on the potent HIV-1 and HIV-2 inhibitors PVAS and PAVAS
|
|
|
1990
|
13 |
S1 |
p. 114-
1 p.
|
artikel
|
| 82 |
Interferon inducers and other biological responses modifiers in murine retrovirus models
|
|
|
1990
|
13 |
S1 |
p. 92-
1 p.
|
artikel
|
| 83 |
Intracellular delivery of oligonucleotides with antiviral properties: Poly(L-lysine) conjugation and liposomes encapsulation
|
|
|
1990
|
13 |
S1 |
p. 125-
1 p.
|
artikel
|
| 84 |
In vitro anti-HIV activity of phosphoprothioate α-anomeric oligodeoxynucleotides
|
|
|
1990
|
13 |
S1 |
p. 75-
1 p.
|
artikel
|
| 85 |
In vitro Anti HIV effect of recombination IFN-α (BDBB hybrid) in macrophages and MT-2 cells
|
|
|
1990
|
13 |
S1 |
p. 92-
1 p.
|
artikel
|
| 86 |
In vitro evaluation of selected new compounds as inhibitors of HIV-1 replication
|
|
|
1990
|
13 |
S1 |
p. 40-
1 p.
|
artikel
|
| 87 |
In vitro Evaluation of the antiviral effects of acemannan on the replication and pathogenesis of HIV-1 and other enveloped viruses: Modification of the processing of glycoprotein precursors
|
|
|
1990
|
13 |
S1 |
p. 83-
1 p.
|
artikel
|
| 88 |
In vitro modulation of the activity of anti-HIV drugs in monocytes by GM-CSF and other cytokines
|
|
|
1990
|
13 |
S1 |
p. 94-
1 p.
|
artikel
|
| 89 |
In vitro sensitivity of herpesvirus simiae (B-virus) to twelve antivirals effective against herpesvirus hominis (H. simplex)
|
|
|
1990
|
13 |
S1 |
p. 58-
1 p.
|
artikel
|
| 90 |
In Vivo administration of tumor necrosis factor-α: Association with antiviral activity in human peripheral mononuclear cells
|
|
|
1990
|
13 |
S1 |
p. 94-
1 p.
|
artikel
|
| 91 |
Isolation and preliminary characterisation of chalcone Ro 09-0410 resistant human rhinovirus type 2
|
|
|
1990
|
13 |
S1 |
p. 85-
1 p.
|
artikel
|
| 92 |
Lack of inhibitory effect of SCH-39304 (an official agent) on the antiviral efficacy of AZT against HIV-1 in vitro
|
|
|
1990
|
13 |
S1 |
p. 80-
1 p.
|
artikel
|
| 93 |
Macrophage membrane lectins: their potential for antiviral drug targeting
|
|
|
1990
|
13 |
S1 |
p. 88-
1 p.
|
artikel
|
| 94 |
Marked inhibition of human immunodeficiency virus type 1 and type 2 by α-(1–3)- and α-(1–6)-D-mannose-specific plant lectins
|
|
|
1990
|
13 |
S1 |
p. 73-
1 p.
|
artikel
|
| 95 |
Mechanism of action of amantadine against the M2 protein of influenza A viruses
|
|
|
1990
|
13 |
S1 |
p. 70-
1 p.
|
artikel
|
| 96 |
Mechanism of action of (±)-(1α,2β,3α)-9-[2,3-Bis(hydroxymethyl)-cyclobutyl]-guanine (BHCG)
|
|
|
1990
|
13 |
S1 |
p. 71-
1 p.
|
artikel
|
| 97 |
Mechanism of cellular uptake of phosphonylmethoxyalkyl purine derivatives
|
|
|
1990
|
13 |
S1 |
p. 86-
1 p.
|
artikel
|
| 98 |
Mechanism of selective inhibition of herpes simplex virus replication by deoxycytidine analogs: Interaction of 5-methoxymethyl-2′-deoxycytidine-5′-triphosphate with DNA polymerases
|
|
|
1990
|
13 |
S1 |
p. 89-
1 p.
|
artikel
|
| 99 |
Mechanisms of augmented resistance of cyclosporin A-treated mice to influenza virus infection by trehalose-6,6′-dimycolate
|
|
|
1990
|
13 |
S1 |
p. 44-
1 p.
|
artikel
|
| 100 |
Metabolism in vitro and pharmacokinetics in vito of 2′-flouro-2′-3′-dideoxyarabinosyladenine (FddA), an inhibitor of HIV with improved stability over 2′,3′-dideoxyadenosine
|
|
|
1990
|
13 |
S1 |
p. 97-
1 p.
|
artikel
|
| 101 |
Mode of action studies on the anti-cytomegalovirus nucleoside analog [1-(2-hydroxy-1-(hydroxymethyl) ethoxymethyl)-cytosine]
|
|
|
1990
|
13 |
S1 |
p. 87-
1 p.
|
artikel
|
| 102 |
Molecular biology of organic thiogold compounds in the chemotherapy of AIDS
|
|
|
1990
|
13 |
S1 |
p. 83-
1 p.
|
artikel
|
| 103 |
Molecular targets for the development of AIDS therapeutics
|
|
|
1990
|
13 |
S1 |
p. 82-
1 p.
|
artikel
|
| 104 |
1-Morpholinomethyl-tetrahydro-2(1H)-pyrimidinone (MCU): Selective inhibitor of influenza virus reproduction
|
|
|
1990
|
13 |
S1 |
p. 124-
1 p.
|
artikel
|
| 105 |
Multivariate data analysis in antiviral research
|
|
|
1990
|
13 |
S1 |
p. 91-
1 p.
|
artikel
|
| 106 |
Observation on antivarial effect of combined treatment on small dose interferon and thymosin in patients with chronic hepatitis B
|
|
|
1990
|
13 |
S1 |
p. 122-
1 p.
|
artikel
|
| 107 |
Oxathiin carboxanilide, a novel potent inhibitor of HIV reproduction
|
|
|
1990
|
13 |
S1 |
p. 42-
1 p.
|
artikel
|
| 108 |
Pathogenicity for man of human rhinovirus type 2 mutants resistant to or dependent on chalcone Ro 09-0410
|
|
|
1990
|
13 |
S1 |
p. 77-
1 p.
|
artikel
|
| 109 |
Pharmacokinetics and safety of anti-HIV-1 TIBO-derivatives in rats, dogs and man
|
|
|
1990
|
13 |
S1 |
p. 97-
1 p.
|
artikel
|
| 110 |
Phosphonylmethoxyalkylpurines and -Pyrimidines in the treatment of HSV keratitis
|
|
|
1990
|
13 |
S1 |
p. 109-
1 p.
|
artikel
|
| 111 |
Phosphonylmethoxyethyl adenine (PMEA) therapy of FeLV-FAIDS infection in cats
|
|
|
1990
|
13 |
S1 |
p. 98-
1 p.
|
artikel
|
| 112 |
Point mutations in the herpes simplex virus DNA polymerase selectively affect sensitivity of the enzyme to novel nucleotide antiviral agents
|
|
|
1990
|
13 |
S1 |
p. 76-
1 p.
|
artikel
|
| 113 |
Preclinical development of recombinant soluble T4 (sT4)
|
|
|
1990
|
13 |
S1 |
p. 96-
1 p.
|
artikel
|
| 114 |
Protective effect of trehalose dimycolate on encephalomyocarditis virus-induced disease in mice
|
|
|
1990
|
13 |
S1 |
p. 93-
1 p.
|
artikel
|
| 115 |
Quantitative measurement of serum neopterin in acute sandfly fever virus (sicilian) infection of medical research volunteer subjects
|
|
|
1990
|
13 |
S1 |
p. 121-
1 p.
|
artikel
|
| 116 |
Qunatitavely different effects of cytokines on chronic HIV-1 infection
|
|
|
1990
|
13 |
S1 |
p. 95-
1 p.
|
artikel
|
| 117 |
Resistance artifact from an automated assay observed in viral isolates from patients with frequent genitical herpes simplex virus (HSV) infections serially treated withy topical 3% edoxudine (EDU) Cream
|
|
|
1990
|
13 |
S1 |
p. 89-
1 p.
|
artikel
|
| 118 |
Ribavirin therapy of acute viral hepatitis “B” and “C’
|
|
|
1990
|
13 |
S1 |
p. 122-
1 p.
|
artikel
|
| 119 |
Rift valley fever virus infected rhesus as a model for drug evaluation: Comparison of prophylaxis with rivavirin or placebo
|
|
|
1990
|
13 |
S1 |
p. 121-
1 p.
|
artikel
|
| 120 |
RNA-intercalating drug interactions: In vitro antiviral activity studies
|
|
|
1990
|
13 |
S1 |
p. 67-
1 p.
|
artikel
|
| 121 |
Safety and efficacy of NPC 567 for the treatment of experimentally induced rhinovirus infections
|
|
|
1990
|
13 |
S1 |
p. 119-
1 p.
|
artikel
|
| 122 |
SCH 38057: A new molecule with broad spectrum inhibitory activity against picornaviruses
|
|
|
1990
|
13 |
S1 |
p. 62-
1 p.
|
artikel
|
| 123 |
Screening of topoisomerase inhibitors for activity against human immunodeficiency virus: Inhibition by coumermycin A1
|
|
|
1990
|
13 |
S1 |
p. 46-
1 p.
|
artikel
|
| 124 |
Selective antiviral agents for the treatment of arenavirus infections
|
|
|
1990
|
13 |
S1 |
p. 60-
1 p.
|
artikel
|
| 125 |
(S)-[3-hydroxy-2-(phosphonylmethoxy)propyl] cytosine (HPMPC); studies on intracellular metabolism and the effect of infrequent dosing on antiviral efficacy
|
|
|
1990
|
13 |
S1 |
p. 111-
1 p.
|
artikel
|
| 126 |
Soluble T4 (sT4) mediates release of gp120 from HIV: Quantitative electron microscopy and biochemical analysis
|
|
|
1990
|
13 |
S1 |
p. 78-
1 p.
|
artikel
|
| 127 |
SQ 33,912: A selective inhibitor of Varicella-Zoster virus replication
|
|
|
1990
|
13 |
S1 |
p. 54-
1 p.
|
artikel
|
| 128 |
SQ 32, 756 (BV-araV): Characteristics and pharmacokinetic evaluation in healthy male volunteers
|
|
|
1990
|
13 |
S1 |
p. 100-
1 p.
|
artikel
|
| 129 |
Structure activity relationship in a series of phosphate derivatives of AZT
|
|
|
1990
|
13 |
S1 |
p. 41-
1 p.
|
artikel
|
| 130 |
Studies of the cellular pharmacology of the carbocyclic guanosine analog carbovir, an inhibitor of human immunodeficiency virus
|
|
|
1990
|
13 |
S1 |
p. 73-
1 p.
|
artikel
|
| 131 |
Studies on the mode of action of R 61837, an antirhinovirus compound
|
|
|
1990
|
13 |
S1 |
p. 85-
1 p.
|
artikel
|
| 132 |
Study of the binding parameters of R 61837 to HRV 9 and immuno-biochemical evidence for a capsid stabilizing activity of the drug
|
|
|
1990
|
13 |
S1 |
p. 84-
1 p.
|
artikel
|
| 133 |
Summary of natural products isolated from marine organisms with antiviral activity against mouse coronavirus.
|
|
|
1990
|
13 |
S1 |
p. 61-
1 p.
|
artikel
|
| 134 |
Susceptibility profiles of ganciclovir-resistant HCMV clinical isolates to several candidate antiviral compounds
|
|
|
1990
|
13 |
S1 |
p. 77-
1 p.
|
artikel
|
| 135 |
Synthesis and anti-HIV activities of diphosphohexose prodrugs of AZDU (Azddu or CS-87)
|
|
|
1990
|
13 |
S1 |
p. 41-
1 p.
|
artikel
|
| 136 |
Synthesis and anti-HIV evaluation of some 5′-O-Phosphonomethyl-2′, 3′-dideoxynucleosides
|
|
|
1990
|
13 |
S1 |
p. 51-
1 p.
|
artikel
|
| 137 |
Synthesis and anti-HIV of 2′,3′-dixeoxy-4′-thionucleosides
|
|
|
1990
|
13 |
S1 |
p. 48-
1 p.
|
artikel
|
| 138 |
Synthesis and anti-retrovirus properties of 5′-isocyano- and 5′-fornamido derivatives of AZT and the corresponding uridine derivatives
|
|
|
1990
|
13 |
S1 |
p. 52-
1 p.
|
artikel
|
| 139 |
Synthesis and antiviral activity of averone aminoacidic derivatives
|
|
|
1990
|
13 |
S1 |
p. 64-
1 p.
|
artikel
|
| 140 |
Synthesis and antiviral activity of 3-(dialkylamino) isoxazoles
|
|
|
1990
|
13 |
S1 |
p. 42-
1 p.
|
artikel
|
| 141 |
Synthesis and antiviral activity of N7-substituted acyclic purine nucleoside analogues. First example of an antivirally active N7-isomer
|
|
|
1990
|
13 |
S1 |
p. 39-
1 p.
|
artikel
|
| 142 |
Synthesis and antiviral evaluation of novel 5,6-dichlorobenzimidazole D -pentofuranonucleosides
|
|
|
1990
|
13 |
S1 |
p. 66-
1 p.
|
artikel
|
| 143 |
Synthesis and antiviral (RNA) evaluation of nucleotide analogs of ribavarian and tiazofurin modified at the carboxamide moiety
|
|
|
1990
|
13 |
S1 |
p. 59-
1 p.
|
artikel
|
| 144 |
Synthesis and enzymology of new D1 deoxynucleosides with anti-HIV potential
|
|
|
1990
|
13 |
S1 |
p. 47-
1 p.
|
artikel
|
| 145 |
Synthesis and in vitro antirhinoviral activity of broad spectrum 6-substituted-3-amino-pyridazines
|
|
|
1990
|
13 |
S1 |
p. 62-
1 p.
|
artikel
|
| 146 |
Synthesis and in vitro antiviral activity of some pyrazole-related nucleosides
|
|
|
1990
|
13 |
S1 |
p. 67-
1 p.
|
artikel
|
| 147 |
Synthesis and in vitro antiviral activity of substituted derivatives of the potent antiviral agent 9-[2-(Phosphonylmethoxy)ethyl]guanine (PMEG)
|
|
|
1990
|
13 |
S1 |
p. 54-
1 p.
|
artikel
|
| 148 |
Synthesis of 2′,3′-deoxy-2′3′-didehydro- and 2′3′-dideoxy-3-deazaadenosine as potential anti-HIV agents
|
|
|
1990
|
13 |
S1 |
p. 53-
1 p.
|
artikel
|
| 149 |
Synthesis of 2′,3′-dideoxy-3′-methylenepyrimidine nucleosides as potential anti-AIDS agents
|
|
|
1990
|
13 |
S1 |
p. 49-
1 p.
|
artikel
|
| 150 |
Targeting of antiviral agents to specific liver cell types by neoglycoproteins
|
|
|
1990
|
13 |
S1 |
p. 91-
1 p.
|
artikel
|
| 151 |
Targeting of anti-viral drugs to HIV infected T4-Lymphocytes: Anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro
|
|
|
1990
|
13 |
S1 |
p. 72-
1 p.
|
artikel
|
| 152 |
The effects of 5-iodo-2′-deoxyuridine( IDU ) and acyclovir ( ACV ) on herpes simplex virus ( HSV ) specific cytotoxic T lymphocytes ( CTL )
|
|
|
1990
|
13 |
S1 |
p. 107-
1 p.
|
artikel
|
| 153 |
The lipophilic muramyl peptide MTP-PE is a potent inhibitor of HIV replication in macrophages
|
|
|
1990
|
13 |
S1 |
p. 44-
1 p.
|
artikel
|
| 154 |
The mechanism of action of Ro 31-8959 on HIV infected cells
|
|
|
1990
|
13 |
S1 |
p. 50-
1 p.
|
artikel
|
| 155 |
The Third International Conference on antiviral research
|
|
|
1990
|
13 |
S1 |
p. 1-37
37 p.
|
artikel
|
| 156 |
TIBO derivatives represent a new lead of potent and selective HIV-1 inhibitors that interact with a reverse transcriptase-associated process
|
|
|
1990
|
13 |
S1 |
p. 48-
1 p.
|
artikel
|
| 157 |
Topical bioavailability of rats of the antiviral drug 2-acetylpyridine thiosemicarbazone
|
|
|
1990
|
13 |
S1 |
p. 100-
1 p.
|
artikel
|
| 158 |
Topical 15% undercylenic acid (UDA) cream vs placebo (PLB): A Canadian, randomized, multicenter, patient-initiated (PI) trial in patients with recurrent oral-labial (OL) herpes simplex virus (HSV) infections
|
|
|
1990
|
13 |
S1 |
p. 102-
1 p.
|
artikel
|
| 159 |
Treatment of experimental ultraviolet radiation(UVR)-induced herpes labialis with peroral and topical acyclovir(ACV)
|
|
|
1990
|
13 |
S1 |
p. 101-
1 p.
|
artikel
|
| 160 |
Treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS (MAIDS)
|
|
|
1990
|
13 |
S1 |
p. 111-
1 p.
|
artikel
|
| 161 |
Ultraviolet radiation (UV) induced recurrent genital herpes: An animal model for evaluating antiviral treatment
|
|
|
1990
|
13 |
S1 |
p. 106-
1 p.
|
artikel
|
| 162 |
Use of isotopically chiral [4′-13C] pencìclovir (BRL 39123) and its oral prodrug [4′-13C] Famciclovir (BRL 42810) to determine the absolute configuration of their metabolites
|
|
|
1990
|
13 |
S1 |
p. 87-
1 p.
|
artikel
|
| 163 |
Use of rimantadine, amantadine, ribavirin and LY253963 for influenza A virus infection in mice and the effects of these agents on immune responses in vivo and in vitro
|
|
|
1990
|
13 |
S1 |
p. 118-
1 p.
|
artikel
|
| 164 |
WC3 Rotavirus vaccine trial: Correlates of protection
|
|
|
1990
|
13 |
S1 |
p. 104-
1 p.
|
artikel
|
| 165 |
Woodchuck hepatitis virus: A model for the development of antiviral therapies against HBV
|
|
|
1990
|
13 |
S1 |
p. 98-
1 p.
|
artikel
|
| 166 |
X-ray structures of the HIV protease complexed with statine-containing peptide inhibitors — implications for structure based drug design
|
|
|
1990
|
13 |
S1 |
p. 74-
1 p.
|
artikel
|
Tijdschrift beschrijving